Brookline Capital Management Stock Recommendations and Price Targets

This is a list of recent ratings by Brookline Capital Management.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
8/15/2022
ATE
Antibe Therapeutics
Reiterated RatingC$1.00BuyN/A
8/10/2022
ARCT
Arcturus Therapeutics
Reiterated Rating$15.00BuyLow
8/8/2022
BCEL
Atreca
Reiterated Rating$2.00BuyLow
6/30/2022
ATBPF
Antibe Therapeutics
Reiterated Rating$0.00BuyN/A
5/18/2022
VERU
Veru
Boost Price Target$12.00$29.00 ➝ $31.00Buy ➝ BuyMedium
4/4/2022
BLPH
Bellerophon Therapeutics
Lower Price Target$1.00$26.00 ➝ $19.00Low
3/10/2022
VRCA
Verrica Pharmaceuticals
Reiterated Rating$3.00BuyMedium
3/7/2022
NTLA
Intellia Therapeutics
Upgrade$56.00 $91.00Hold ➝ BuyHigh
3/1/2022
CTIC
CTI BioPharma
Boost Price Target$6.00$7.20 ➝ $12.00Buy ➝ BuyHigh
2/14/2022
CRBU
Caribou Biosciences
Reiterated Rating$11.00BuyMedium
2/14/2022
CRSP
CRISPR Therapeutics
Reiterated Rating$65.00 $143.00BuyHigh
2/14/2022
NTLA
Intellia Therapeutics
Reiterated Rating$56.00BuyLow
2/3/2022
BCDA
BioCardia
Reiterated Rating$2.00BuyHigh
2/2/2022
FUSN
Fusion Pharmaceuticals
Reiterated Rating$3.00BuyMedium
2/1/2022
ICCM
IceCure Medical
Reiterated Rating$1.00BuyLow
1/26/2022
HEPA
Hepion Pharmaceuticals
Reiterated Rating$1.00BuyLow
1/19/2022
DARE
Daré Bioscience
Reiterated Rating$1.00BuyHigh
12/14/2021
PROC
Procaps Group
Reiterated Rating$7.00 $13.00BuyLow
12/1/2021
PNT
POINT Biopharma Global
Reiterated Rating$8.00 $23.00BuyMedium
11/15/2021
CTIC
CTI BioPharma
Reiterated Rating$6.00BuyHigh
10/19/2021
NOVN
Novan
Reiterated Rating$2.00 $16.00BuyMedium
10/13/2021
ADIL
Adial Pharmaceuticals
Reiterated Rating$0.00 $12.00BuyHigh
10/13/2021
KYMR
Kymera Therapeutics
Reiterated Rating$22.00 $80.00BuyMedium
10/8/2021
BIOC
Biocept
Reiterated Rating$1.00BuyMedium
9/21/2021
DRMA
Dermata Therapeutics
Reiterated Rating$1.00 $14.00BuyHigh
9/3/2021
FBRX
Forte Biosciences
Reiterated Rating$1.00HoldLow
8/27/2021
VERU
Veru
Reiterated Rating$12.00BuyMedium
8/24/2021
SCYX
SCYNEXIS
Reiterated Rating$2.00BuyLow
7/29/2021
BCEL
Atreca
Reiterated Rating$2.00BuyHigh
6/25/2021
CCCC
C4 Therapeutics
Reiterated Rating$9.00BuyHigh
6/23/2021
BLPH
Bellerophon Therapeutics
Reiterated Rating$1.00BuyMedium
6/3/2021
ATBPF
Antibe Therapeutics
Reiterated Rating$0.00BuyMedium
6/3/2021
ATE
Antibe Therapeutics
Reiterated RatingC$1.00BuyN/A
5/25/2021
MNPR
Monopar Therapeutics
Reiterated Rating$2.00BuyMedium
5/7/2021
BIOX
Bioceres Crop Solutions
Reiterated Rating$13.00BuyN/A
3/30/2021
ONCT
Oncternal Therapeutics
Reiterated Rating$1.00 $16.00BuyHigh
3/30/2021
SQZ
SQZ Biotechnologies
Reiterated Rating$2.00BuyN/A
3/25/2021
NMTR
9 Meters Biopharma
Reiterated Rating$0.00BuyHigh
3/12/2021
NLSP
NLS Pharmaceutics
Initiated Coverage$1.00 $12.00BuyHigh
2/26/2021
MRNA
Moderna
Boost Price Target$118.00$180.00 ➝ $205.00BuyLow
2/2/2021
CNSP
CNS Pharmaceuticals
Initiated Coverage$0.00 $10.00BuyLow
12/17/2020
XFOR
X4 Pharmaceuticals
Initiated Coverage$2.00 $21.00BuyHigh
12/14/2020
VERU
Veru
Boost Price Target$12.00$13.00 ➝ $17.00High
11/10/2020
SYRS
Syros Pharmaceuticals
Initiated Coverage$6.00 $190.00BuyLow
10/23/2020
ECOR
electroCore
Initiated Coverage$0.00 $5.00BuyLow
10/23/2020
CTIC
CTI BioPharma
Initiated Coverage$6.00 $7.00BuyMedium
10/14/2020
AWH
Aspira Women's Health
Reiterated Rating$0.00BuyHigh
10/12/2020
MEIP
MEI Pharma
Reiterated Rating$0.00BuyMedium
9/11/2020
DMTK
DermTech
Initiated Coverage$4.00BuyHigh
8/28/2020
FBRX
Forte Biosciences
Initiated Coverage$1.00 $90.00BuyLow
8/24/2020
MDNA
Medicenna Therapeutics
Reiterated Rating$1.00BuyMedium
8/20/2020
HUGE
FSD Pharma
Initiated Coverage$1.00 $11.00BuyN/A
8/20/2020
HUGE
FSD Pharma
Reiterated Rating$1.00BuyLow
8/18/2020
NMTR
9 Meters Biopharma
Initiated Coverage$0.00 $5.00BuyHigh
8/16/2020
KURA
Kura Oncology
Reiterated Rating$14.00BuyLow
8/14/2020
VERU
Veru
Reiterated Rating$12.00BuyLow
8/11/2020
ARCT
Arcturus Therapeutics
Reiterated Rating$15.00BuyLow
7/15/2020
ATE
Antibe Therapeutics
Reiterated RatingC$1.00BuyN/A
7/13/2020
MRNA
Moderna
Reiterated Rating$118.00 $95.00BuyHigh
6/3/2020
ASRT
Assertio
Initiated Coverage$2.00 $3.50BuyLow
5/28/2020
CWBR
CohBar
Initiated Coverage$3.00BuyN/A
5/27/2020
CWBR
CohBar
Reiterated Rating$3.00BuyMedium
5/19/2020
CYCC
Cyclacel Pharmaceuticals
Initiated Coverage$1.00 $22.00BuyHigh
5/14/2020
BIOC
Biocept
Initiated Coverage$1.00BuyHigh
5/5/2020
OTLK
Outlook Therapeutics
Initiated Coverage$1.00BuyHigh
4/28/2020
DARE
Daré Bioscience
Initiated Coverage$1.00 $7.50BuyHigh
4/14/2020
BLPH
Bellerophon Therapeutics
Initiated Coverage$1.00 $35.00BuyLow
3/30/2020
EDSA
Edesa Biotech
Initiated Coverage$1.00 $10.00BuyHigh
3/13/2020
ARMP
Armata Pharmaceuticals
Reiterated Rating$4.00BuyHigh
3/12/2020
CLPT
ClearPoint Neuro
Initiated Coverage$10.00 $15.00BuyN/A
3/11/2020
CLPT
ClearPoint Neuro
Reiterated Rating$10.00BuyHigh
2/19/2020
MNPR
Monopar Therapeutics
Initiated Coverage$2.00 $42.00BuyHigh
2/4/2020
BIOX
Bioceres Crop Solutions
Reiterated Rating$13.00BuyN/A
11/26/2019
BCDA
BioCardia
Reiterated Rating$2.00BuyLow
11/26/2019
BCDA
BioCardia
Initiated Coverage$2.00 $22.00BuyLow
11/19/2019
MDNA
Medicenna Therapeutics
Reiterated RatingC$1.00 C$4.00BuyN/A